{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-24-000030","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.716834+00:00","generated_at":"2026-06-03T04:59:43.241008+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tenet Q1 adj EPS $3.22 beats; revenue $5.37B; raises FY2024 EBITDA outlook to $3.5-3.7B","bullets":["Q1 net income $2.15B ($21.38 diluted) includes $1.86B after-tax gain from hospital sales; adjusted diluted EPS $3.22.","Consolidated revenue $5.37B (+6.9% YoY); Adjusted EBITDA $1.02B (+23.1% YoY).","Ambulatory segment Adjusted EBITDA $394M (+15.9% YoY); Hospital segment Adjusted EBITDA $630M (+28.0% YoY).","FY2024 Adjusted EBITDA outlook raised by $215M to $3.50-$3.70B; Q2 guidance: $835-$885M.","Repurchased 2.8M shares for $278M; retired $2.1B of 4.875% notes due 2026, reducing annual cash interest by $102M."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-24-000030","json":"https://secwatch.observer/filing/0000070318-24-000030.json","markdown":"https://secwatch.observer/filing/0000070318-24-000030.md","text":"https://secwatch.observer/filing/0000070318-24-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000030/0000070318-24-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000030/thc-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:59:43.241008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"33a31b278dfccc875be9a9283786d785923d0c2a","claim":"TENET HEALTHCARE CORP reported quarter ended March 31, 2024 results: revenue $5,368, net income $2,151, EPS $21.38. Guidance raised.","evidence_excerpt":"results for first quarter 2024 versus first quarter 2023 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2024 2023 Net operating revenues $5,368 $5,021 Net income available to Tenet common shareholders from continuing operations $2,151 $143 Net income available to Tenet common shareholders from continuing operations per","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000030/0000070318-24-000030-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2024"},{"label":"Revenue","value":"$5,368"},{"label":"Net income","value":"$2,151"},{"label":"EPS","value":"$21.38"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}